Candriam Equities L Oncology Impact I/  LU1864482515  /

Fonds
NAV6/4/2024 Chg.+8.8101 Type of yield Investment Focus Investment company
2,201.1001GBP +0.40% reinvestment Equity Worldwide Candriam